PIM
SGMT icon

Platinum Investment Management’s Sagimet Biosciences SGMT Stock Holding History

Platinum Investment Management’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-90,633
Closed -$491K – 146
2024
Q1 		$491K Sell
90,633
-21,119
-19% -$152K 0.02% 93
2023
Q4 		$606K Sell
111,752
-272,161
-71% -$1.28M 0.02% 96
2023
Q3 		$3.38M Buy
+383,913
New +$5.11M 0.13% 58

Other funds holding SGMT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Platinum Investment Management's SGMT Position: Q2 2024 in Review

Platinum Investment Management sold out of Sagimet Biosciences (SGMT) in Q2 2024, closing a stake of 90,633 shares — an estimated $491K sold.

Platinum Investment Management first reported a position in SGMT in Q3 2023 and held it in 3 quarters. The position peaked at $3.38M in Q3 2023. 82 funds tracked by Wall St. Rank hold SGMT as of Q2 2024.

  • Platinum Investment Management reported no remaining Sagimet Biosciences position as of Q2 2024 after selling out during the quarter.
  • Platinum Investment Management sold 90,633 Sagimet Biosciences shares in Q2 2024, an estimated $491K.
  • Platinum Investment Management first reported a position in Sagimet Biosciences in Q3 2023 and held it in 3 quarters.
  • Platinum Investment Management's Sagimet Biosciences position peaked at $3.38M in Q3 2023.
  • 82 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2024.

Based on Platinum Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.